Ro partners with Amgen to study barriers to obesity care, GLP-1 access

U.S. telehealth firm Ro said on Tuesday it has entered a research collaboration with drugmaker Amgen to examine challenges patients and providers face in accessing obesity treatments, including GLP-1 ... ...